Despite recent research having demonstrated the strong association of RUNX1 mutations in a variety of hematological malignancies, it is unclear how RUNX1 mutations contribute to the pathogenesis of hematological malignancies in IBMFS. The gene discussed is RUNX1; the disease is hematologic disorder.